Leukemia Chief Editor

Fred Appelbaum, MD

Fred Appelbaum, MD

Frederick R. Appelbaum, MD, is Director of the Clinical Research Division, Fred Hutchinson Cancer Research Center, Head of Oncology, University of Washington School of Medicine, and President and Executive Director of the Seattle Cancer Care Alliance. He is a diplomat on the American Boards of Internal Medicine and Medical Oncology, and is past chair of the Board of Scientific Advisors of the National Cancer Institute. Additionally, he has been a board member of a number of scientific societies, including the American Society of Hematology, American Society of Clinical Oncology, the American Society for Blood and Marrow Transplantation and is Chair of the Leukemia Committee of the Southwest Oncology Group. Dr. Appelbaum served two terms as Associate Editor for Blood and also serves on the Editorial Boards of numerous scientific journals. Dr. Appelbaum is Head of the Clinical Transplant Research Program in the FHCRC/University of Washington Cancer Consortium and Principal Investigator on several National Institutes of Health grants. He is the author of over 800 scientific articles and was the lead author on the first paper to describe the successful use of autologous marrow transplantation. Dr. Appelbaum’s current areas of research interests center on the biology and treatment of hematologic malignancies.

Leukemia Editorial Board

Jerald P. Radich, MD

Jerald P Radich MD

Dr. Jerald Radich is a Member of the Clinical Research Division and Director the Molecular Oncology Lab at the Fred Hutchinson Cancer Research Center, and Professor of Medicine at the University of Washington School of Medicine. He is Chair of the Leukemia Translational Medicine Committee of the Southwest Oncology Group,  co-chair of the NCI/NIH Leukemia Steering Committee, and is on the Board of Scientific Counselors, NIH Genome Research Institute.  He belong to the National Comprehensive Cancer Network (NCCN) and the EuroLeukemiaNet (ELN) CML committees, and is on the Scientific Board of the International CML Foundation. Dr. Radich’s laboratory work centers on the molecular biology of response, resistance, and progression in adult and chronic leukemia.

Guido Marcucci MD

Gail J. Roboz, MD

Gail J. Roboz, MD

Gail J. Roboz, M.D. is Associate Professor of Medicine and Director of the Leukemia Program at the Weill Medical College of Cornell University and the New York Presbyterian Hospital in New York City.

Dr. Roboz graduated summa cum laude from Yale University and received her medical degree from The Mount Sinai School of Medicine in New York, where she was elected to the Alpha Omega Alpha Honor Medical Society and achieved the highest academic standing in the graduating class.  She completed Internship in internal medicine at The Beth Israel Hospital in Boston and Residency in internal medicine at the New York Presbyterian Hospital.  Dr. Roboz was a Fellow in hematology and medical oncology at Weill Cornell/New York-Presbyterian Hospital and is board-certified in both specialties. She is a member of the American Society of Hematology and the American Society of Clinical Oncology.  Her research interests are in developmental therapeutics for acute leukemia, myelodysplastic syndrome and myeloproliferative disorders.  Dr. Roboz is the principal investigator on investigator-initiated and industry-sponsored clinical trials in these areas and has authored or coauthored many manuscripts and abstracts.  She sits on the editorial boards of and acts as a reviewer for several journals, and has played an active role as a speaker and panelist at numerous regional, national and international conferences.  Dr. Roboz also serves on the Medical Advisory Board of the Aplastic Anemia and MDS International Foundation.